From: Health care needs of cancer survivors in general practice: a systematic review
Author & year | Study design* | Nr. of participants | Mean age at interview** | Sex: male (%) | Cancer type** | Specification of cancer type** | Study country |
---|---|---|---|---|---|---|---|
Qualitative studies | |||||||
Eardley 1990 [25] | I | 44 | 71 | 91 | Mix | bladder and prostate | UK |
Hudson 2012 [26] | I | 42 | 65 (47–80) | 43 | Mix | 24 breast, 18 prostate | USA |
Khan 2011 [30] | I | 40 | 20% <60 25% 61–70 40% 71–80 15% >81 | 45 | Mix | 15 breast, 13 CRC, 12 prostate | UK |
Rozmovits 2004 [33] | I | 39 | 60 (33–87) | 51 | CRC | UK | |
Adams 2011 [24] | I | 38 | 21% <50 37% 50–70 42% >70 | 50 | Mix | 9 breast, 6 prostate, 4 CRC, 4 head/neck, 3 lung, 3 melanoma, 2 testis, 2 gynaecologic, 2 Hodgkin, 1 NHL, 1 bladder, 1 renal | UK |
Norman 2001 [32] | I | 25 | 58 (28–84) | 44 | Mix | 11 primary cancer sites, most common: breast and lung | Canada |
Kantsiper 2009 [28] | G | 21 | - | 0 | Breast | USA | |
Sahay 2000 [34] | I | 20 | 65 (48–87) | - | CRC | Canada | |
Aabom 2009 [23] | I^ | 16 | 65 (50–80) | 75 | Mix | 6 rectum, 8 colon, 2 pancreas | Denmark |
Kendall 2006 [29] | G | 16 | 53 (35–70) | 50 | Mix | 3 breast, 3 bowel, 3 haematological, 2 prostate, 1 testis, 1 Hodgkin, 1 lung, 2 unknown | UK |
Lydon 2009 [31] | G | 6 | 64 (52–73) | 0 | Ovarian | UK | |
Jiwa 2006 [27] | G | - | - | - | Breast | ||
Quantitative studies | |||||||
Cheung 2009 [35] | - | 431 | 57 (16–91) | 27 | Mix | 216 breast, 43 genitourinary, 39 hematologic, 30 gastrointestinal, 26 head/neck, 21 lung, 17 gynaecologic, 28 other, 21 unreported | USA |
Sisler 2004 [37] | - | 200 | 16% ≤49 17% 50–59 30% 60–69 37% ≥70 | 45 | Mix | 54 breast, 39 prostate, 24 CRC, 25 lung, 14 reproductive organs, 56 other | Canada |
De Padova 2011 [36] | - | 32 | 36 (22–60) | 100 | Testis | Italy |